Literature DB >> 17641057

Multiple chemokine receptors, including CCR6 and CXCR3, regulate antigen-induced T cell homing to the human asthmatic airway.

Seddon Y Thomas1, Aleena Banerji, Benjamin D Medoff, Craig M Lilly, Andrew D Luster.   

Abstract

Human allergic asthma is a chronic inflammatory disease of the airways thought to be driven by allergen-specific Th2 cells, which are recruited into the lung in response to inhaled allergen. To identify chemoattractant receptors that control this homing pattern, we used endobronchial segmental allergen challenge in human atopic asthmatics to define the pattern of chemoattractant receptor expression on recruited T cells as well as the numbers of recruited CD1d-restricted NKT cells and levels of chemokines in the bronchoalveolar (BAL) fluid. CD1d-restricted NKT cells comprised only a small minority of BAL T cells before or after Ag challenge. BAL T cells were enriched in their expression of specific chemoattractant receptors compared with peripheral blood T cells prechallenge, including CCR5, CCR6, CXCR3, CXCR4, and BLT1. Surprisingly, following segmental allergen challenge, no chemoattractant receptor was specifically increased. However, CCR6 and CXCR3, which were expressed on virtually all CD4(+) BAL T cells prechallenge, were markedly decreased on all recruited BAL T cells following Ag challenge, suggesting that these receptors were internalized following encounter with ligand in the airway. Our data therefore suggests a role for CCR6 and CXCR3, in conjunction with other chemoattractant receptors, in the recruitment of inflammatory T cells into the BAL during the allergic asthmatic response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641057     DOI: 10.4049/jimmunol.179.3.1901

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

Review 1.  Natural killer T cells are important in the pathogenesis of asthma: the many pathways to asthma.

Authors:  Dale T Umetsu; Rosemarie H Dekruyff
Journal:  J Allergy Clin Immunol       Date:  2010-03-24       Impact factor: 10.793

Review 2.  The role of chemokines in virus-associated asthma exacerbations.

Authors:  Lara E Kallal; Nicholas W Lukacs
Journal:  Curr Allergy Asthma Rep       Date:  2008-09       Impact factor: 4.806

3.  Many Roles of CCL20: Emphasis on Breast Cancer.

Authors:  Kingsley O Osuala; Bonnie F Sloane
Journal:  Postdoc J       Date:  2014-03

4.  Cysteine-cysteinyl chemokine receptor 6 mediates invariant natural killer T cell airway recruitment and innate stage resistance during mycobacterial infection.

Authors:  Valerie R Stolberg; Bo-chin Chiu; Brian E Martin; Samir A Shah; Matyas Sandor; Stephen W Chensue
Journal:  J Innate Immun       Date:  2010-10-29       Impact factor: 7.349

5.  CARMA3 Is Critical for the Initiation of Allergic Airway Inflammation.

Authors:  Benjamin Causton; Ravisankar A Ramadas; Josalyn L Cho; Khristianna Jones; Ana Pardo-Saganta; Jayaraj Rajagopal; Ramnik J Xavier; Benjamin D Medoff
Journal:  J Immunol       Date:  2015-06-03       Impact factor: 5.422

Review 6.  CXCR3 ligands: redundant, collaborative and antagonistic functions.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

Review 7.  Thymic stromal lymphopoietin: a new cytokine in asthma.

Authors:  Yrina Rochman; Warren J Leonard
Journal:  Curr Opin Pharmacol       Date:  2008-04-29       Impact factor: 5.547

Review 8.  Regulation of G-protein-coupled signaling pathways in allergic inflammation.

Authors:  Kirk M Druey
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

9.  Polarized localization of epithelial CXCL11 in chronic obstructive pulmonary disease and mechanisms of T cell egression.

Authors:  Joanna C Porter; Mary Falzon; Alan Hall
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

Review 10.  The cytokine network in asthma and chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.